DANIELLE GRONTAS: Open Payments
NPI 1497500805 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 27 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $176 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $212 |
| Vanda Pharmaceuticals Inc. | 3 | $62 |
| Lundbeck LLC | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Amgen Inc. | 3 | $52 |
| Exact Sciences Corporation | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $17 |
Products named: Ozempic, REXULTI, FANAPT, FARXIGA, OTEZLA, Cologuard Collection Kit, Rybelsus, CAPVAXIVE.
Industry payments across FL — which companies pay providers there.
